We are live on ! Find out more
PPH icon

VanEck Pharmaceutical ETF
PPH

91 hedge funds and large institutions have $346M invested in VanEck Pharmaceutical ETF in 2022 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 35 increasing their positions, 8 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more capital invested

Capital invested by funds: $70.5M → $346M (+$276M)

338% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 8

317% more call options, than puts

Call options by funds: $4.83M | Put options by funds: $1.16M

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

45.3% more ownership

Funds ownership: 19.22% → 64.52% (+45%)

21% more funds holding

Funds holding: 75 → 91 (+16)

Holders
91
Holders Change
+16
Holders Change %
+21.33%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
27
Increased
35
Reduced
8
Closed
10
Calls
$4.83M
Puts
$1.16M
Net Calls
+$3.67M
Net Calls Change
+$4.25M

Top Buyers

Rank Fund Capital Flow
1
PF
Phoenix Financial
Israel
+$164M
2
UBS Group
UBS Group
Switzerland
+$37.6M
3
Goldman Sachs
Goldman Sachs
New York
+$16.6M
4
Morgan Stanley
Morgan Stanley
New York
+$11.5M
5
NC
Noked Capital
Israel
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
-$2.77M
2
LJAC
L.J. Altfest & Co
New York
-$1.42M
3
Citadel Advisors
Citadel Advisors
Florida
-$946K
4
GA
GFS Advisors
Texas
-$518K
5
CS
Credit Suisse
Switzerland
-$504K
Name Holding Trade Value Shares
Change 		Change in
Stake
MOS
26
MGO One Seven
Ohio
$1.1M +$1.12M +14,304 New
RJA
27
Raymond James & Associates
Florida
$1.03M +$151K +1,929 +17%
BHB
28
Bank Hapoalim BM
Israel
$961K +$113K +1,449 +13%
AWM
29
Axxcess Wealth Management
California
$952K – – –
RFWA
30
RPg Family Wealth Advisory
Massachusetts
$846K +$291K +3,731 +51%
Cohen & Steers
31
Cohen & Steers
New York
$757K +$769K +9,855 New
NL
32
NVWM LLC
Pennsylvania
$751K +$763K +9,776 New
PPG
33
Peak Planning Group
Colorado
$722K +$734K +9,400 New
Simplex Trading
34
Simplex Trading
Illinois
$618K +$622K +7,961 +8,846%
TWM
35
Tradition Wealth Management
Minnesota
$551K – – –
LNWWM
36
Laird Norton Wetherby Wealth Management
California
$538K +$273K +3,500 +100%
EDRH
37
Edmond de Rothschild Holding
Switzerland
$485K +$301K +3,850 +156%
BCM
38
Barometer Capital Management
Ontario, Canada
$466K +$461K +5,900 New
APA
39
American Portfolios Advisors
New York
$435K +$230K +2,952 +109%
BI
40
Berkeley Inc
Idaho
$411K +$625 +8 +0.1%
Marshall Wace
41
Marshall Wace
United Kingdom
$404K +$49K +628 +14%
GCA
42
Greenwood Capital Associates
South Carolina
$400K -$2.03K -26 -0.5%
RAM
43
Riggs Asset Management
Pennsylvania
$394K +$401K +5,133 New
TRCT
44
Tower Research Capital (TRC)
New York
$371K +$377K +4,830 New
LSPW
45
Lake Street Private Wealth
Illinois
$370K +$376K +4,818 New
Wells Fargo
46
Wells Fargo
California
$360K +$31.2K +400 +9%
JMPWA
47
JP Morgan Private Wealth Advisors
California
$352K +$131K +1,681 +58%
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$309K +$314K +4,021 New
AWM
49
AE Wealth Management
Kansas
$268K +$272K +3,490 New
KIA
50
KCM Investment Advisors
California
$264K -$9.37K -120 -3%
1
2
3 4

PPH Hedge Fund Activity: Q2 2022 in Review

91 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in VanEck Pharmaceutical ETF (PPH) for Q2 2022, worth a combined $346M — up 392% from $70.5M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PPH positions and 10 closed out — a net gain of 17 holders — while 35 added to existing stakes and 8 trimmed.

The largest buyer was Phoenix Financial, adding an estimated $164M. The largest seller was Clough Capital Partners, exiting entirely with an estimated $2.77M sold.

  • 91 institutional investors held VanEck Pharmaceutical ETF (PPH) as of Q2 2022, up from 75 in Q1 2022.
  • Funds reported $346M of VanEck Pharmaceutical ETF stock for Q2 2022, up 392% quarter-over-quarter.
  • 27 funds opened new VanEck Pharmaceutical ETF positions in Q2 2022 and 10 closed out, a net change of +17 holders.
  • The largest VanEck Pharmaceutical ETF buyer in Q2 2022 was Phoenix Financial, an estimated $164M added.
  • The largest VanEck Pharmaceutical ETF seller in Q2 2022 was Clough Capital Partners, an estimated $2.77M sold.

Based on aggregated 13F filings for Q2 2022.